Atypical neuroleptics in children and adolescents;Neuroleptiques atypiques chez l'enfant et l'adolescent

Encephale

Volumn 24, Issue 4, 1998, Pages 378-385

  Naja, W J ^a   Reneric, J P ^b   Bouvard, M P ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b CH Charles Perrens ^*  (France)

Author keywords

Adolescents; Children; Clozapine; Risperidone; VEOS

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

ADOLESCENT; CHILD; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; HEMATOLOGIC DISEASE; HUMAN; REVIEW; SCHIZOPHRENIA;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CHILD; CLOZAPINE; DRUG MONITORING; HUMANS; RISPERIDONE; SCHIZOPHRENIA, CHILDHOOD; TREATMENT OUTCOME;

EID: 0031679887     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. ANDERSON GM, FREDMAN DX, COHEN DJ et al. Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 1988 ; 28 : 885-900.
2. ARMENTEROS JL, WHITAKER AH, WELIKSON M et al. Risperidone in adolescents with schizophrenia : an open pilot study. J Am Acad Child Adolesc Psychiatry 1997 ; 36 (5) : 694-700.
3. BIRMAHER B, BAKER R, KAPUR S et al. Case study, clozapine for the treatment of adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 1992 ; 31 (1) : 160-4.
4. BRUUN RD, BUDMAN CL. Risperidone as a treatment for Tourette's syndrome. J Clin Psychiatry 1996 ; 57 : 29-31.
5. BUZAN RD. Risperidone-induced tardive dyskinesia [letter]. Am J Psychiatry 1996 ; 153 : 734-5.
6. BYMASTER FP, CALLIGARO DO, FALCONE JF et al. Radio-receptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 1996 ; 14 : 87-96.
7. CAMPBELL M, ADAMS P, PERRY R et al. Tardive and withdrawal dyskinesia in autistic children : a prospective study. Psychopharmacol Bull 1988 ; 24 : 251-5.
8. CAMPBELL M, ANDERSON LT, MEIER M et al. A comparison of haloperidol and behavior therapy and their interaction in autistic children. J Am Acad Child Psychiatry 1978 ; 17 : 640-65.
9. CASAER P, WALLEGHEM D, VANDENBUSSCHE I et al. Pharmacokinetics and safety of risperidone in autistic children. Pediatr Neurol 1994 ; 11 : 89.
10. CHOUINARD G, JONES B, REMINGTON G et al. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 1993 ; 13 : 25-40.
11. Conference Review, The First International Risperidone Investigators Meetings, Paris : 1992.
12. COWARD DM, IMPERATO A, URWYLER S et al. Biochemical and behavioural properties of clozapine. Psychopharmacology 1989 ; 99 : 56-512.
13. COZZA SJ, EDISON DL. Risperidone in adolescents [letter]. J Am Acad Child Adolesc Psychiatry 1994 ; 33 (8) : 1211.
14. CZICK V, MOLNAR J. Possible adverse interaction between clozapine and ampicillin in an adolescent with schizophrenia. J Child Adolesc Psychopharmacol 1994 ; 4 (2) : 123-8.
15. CZOBOR P, VOLAVKA J. Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients. J Clin Psychopharmacol 1993 ; 13 : 332-42.
16. DANIEL DG, SMITH K, HYDE T, EGAN M. Neuroleptic-induced tardive dyskinesia [letter]. Am J Psychiatry 1996 ; 153 : 734.
17. DELAY J, DENIKER P. Méthodes chimiothérapeutiques en Psychiatrie. Paris : Masson 1961 : 496 p.
18. DEMB HB. Risperidone in young children with pervasive developmental disorders and other developmental disabilities. J Child Adolesc Psychopharmacol 1996 ; 6 : 79-80.
19. EDLEMAN RJ. Risperidone side effects [letter]. J Am Acad Child Adolesc Psychiatry 1996 ; 35 (1) : 4-5.
20. FEENEY DJ, KLYKYLO W. Risperidone and tardive dyskinesia [letter]. J Am Acad Child Adolesc Psychiatry 1996 ; 35 (11) : 1421-2.
21. FRAZIER JA, GORDON CT, Mc KENNA K et al. An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 1994 ; 33 (5) : 658-63.
22. FREEDMAN JE, WIRSHING WC et al. Absence status seizures during successful long-term clozapine treatment of an adolescent with schizophrenia. J Child Adolesc Psychopharmacol 1994 ; 4 : 53-62.
23. FUCHS CD. Clozapine treatment of bipolar disorder in young adolescent. J Am Acad Child Adolesc Psychiatry 1994 ; 33 : 1299-302.
24. GUALTIERI CT, SCHROEDER SR, QUADE D. Tardive dyskinesia in young mentally retarded individuals. Arch Gen Psychiatry 1986 ; 43 : 335-40.
25. HARDAN A, JOHNSON K, JOHNSON C et al. Case study : risperidone treatment of children and adolescents with developmental disorders. J Am Acad Child Adolesc 1996 ; 35 (11) : 1551-6.
26. Investigator's Brochure, Risperidone. Janssen Research Foundation, 1992.
27. JACKSON D M, RYAN C, EVENDEN J et al. Preclinical findings with new antipsychotic agents : what makes them atypical ? Acta Psychiatr Scand 1994 ; 89 (Suppl 380) : 41-8.
28. JACOBSEN LK, WALKER MC, EDWARDS JE et al. Clozapine in the treatment of a young adolescent with schizophrenia. J Am Acad Child Adolesc Psychiatry 1994 ; 33 (5) : 645-50.
29. JALENQUES I, COUDERT AJ. Clozapine et schizophrénies résistantes. Etude prospective à long terme chez 20 patients. Encephale 1994 ; XX : 767-75.
30. JANN MC. Clozapine. Pharmacotherapy 1991 ; 11 (3) : 179-95.
31. 2 antagonistic properties. J Pharmacol Exp Ther 1988 ; 244 : 685-93.
32. KEWIN RW. The new atypical antipsychotics. Br J Psychiatry 1994 ; 164 : 141-8.
33. KLESER E, STRAUSS WH, LEMMER W. The tolerability and efficacy of the atypical neuroleptic remoxipride compared with clozapine and haloperidol in acute schizophrenia. Acta Psychiatr Scand 1994 ; 89 (Suppl 380) : 68-73.
34. KUMRA S, HERION D, JACOBSEN LK et al. Case study : risperidone-induced hepatotoxicity in pediatric patients. J Am Acad Child Adolesc Psychiatry 1997 ; 36 (5) : 701-5.
35. LEWANDER T. Overcoming the neuroleptic-induced deficit syndrome : clinical observations with remoxipride. Acta Psychiatr Scand 1994 ; 89 (Suppl 380) : 64-7.
36. LEYSEN JE, JANSEN PMF, MEGENS AAHP et al. Risperidone : a novel antipsychotic with balanced seretonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatry 1994 ; 55 (Suppl 5) : 5-12.
37. LEYSEN JE, GOMMEREN W, EENS A et al. Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther 1988 ; 247 : 661-70.
38. LOMBROSO PJ, SCAHILL L, KING RA et al. Risperidone treatment of children and adolescents with chronic tic disorders : a preliminary report. J Am Acad Child Adolesc Psychiatry 1995 ; 34 (9) : 1147-52.
39. MANDOKI MW. Anti-agressive effects of clozapine in children and adolescents. Biological Psychiatry 1994 ; 35 : 744-5 (Abs. 469).
40. MANDOKI MW. Risperidone treatment of children and adolescents : increased risks of extrapyramidal side effects ? J Child Adolesc Psychopharmacol 1995 ; 5 : 49-67.
41. MARDER SR, MEIBACH RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994 ; 151 : 825-35.
42. McDOUGLE CJ, HOLMES JP, BRONSON MR et al. Risperidone treatment of children and adolescents with pervasive developmental disorders : a prospective open-label study. J Am Acad Child Adolesc Psychiatry 1997 ; 36 : 685-93.
43. MOZES T, TOREN P, CHERNANZAN N et al. Clozapine treatment in very early onset schizophrenia. J Am Acad Child Adolesc Psychiatry 1994 ; 33 : 65-70.
44. MOUREN-SIMEONI MC, BOUVARD MP. Médicaments psychotropes chez l'enfant. Règles de prescription et tolérance. Editions techniques. Encycl Méd Chir (Paris-France), Psychiatrie 1994 ; 37 : 218-A-30 ; 6 p.
45. MOUREN-SIMEONI MC et al. La psychopharmacologie chez l'enfant. Nodules, PUF, 1991 : 101-2.
46. NARUSE H, NAGAHATA M, NAKANE Y et al. A multi-center double-blind trial of pimozide (Orap), haloperidol and placebo in children with behavior disorders, using cross-over design. Acta Paedopsychiatr 1982 ; 48 : 173-84.
47. PISCITTELLI SC, PHARM D, Mc KENNA K et al. Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia : association with response. J Clin Psychiatry 1994 ; 55 (9, suppl B) : 94-7.
48. PIVEN J, TSAIG, NEHME E et al. Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord 1991 ; 21 : 51-9.
49. POVLSEN UJ, NORING U, GERLACH G. Tolerability and therapeutic effect of clozapine. Acta Psychiatr Scand 1985 ; 71 : 176-85.
50. PURDON SE, LIT W, LABELLE A et al. Risperidone in the treatment of pervasive developmental disorder. Can J Psychiatry 1994 ; 39 : 400-5.
51. QUINTANA H, KESHAVAN M. Case study : risperidone in children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 1995 ; 34 : 1292-6.
52. REMSCHMIDT H, SCHULZ E, MATHIAS MARTIN PD. An open trial of clozapine in thirty-six adolescents with schizophrenia. J Child Adolesc Psychopharmacol 1994 ; 4 : 31-41.
53. RICHARDSON MA, HAUGHLAND G, PASS R et al. The prevalence of tardive dyskinesia in a mentally retarded population. Psychopharmacol Bull 1986 ; 22 : 243-9.
54. SCHMIDT MH, TROTT GE, BLANZ B et al. Clozapine medication in adolescents. Psychiatry : a world perspective, vol. 1, Proceedings 8th World Congress of Psychiatry, 1990, Athens (Greece), October 12-19, 1989.
55. SCHOLLER NR. Negative symptoms in schizophrenia : assessment of the effect of risperidone. J Clin Psychiatry 1994 ; 55 (Suppl 5) : 22-8.
56. SCHOTTE A, JANSSEN PFM, GOMEREN W et al. Risperidone compared with new and reference antipsychotic drugs : in vitro and in vivo receptor binding. Psychopharmacology 1996 ; 124 : 57-73.
57. SHAPIRO E, SHAPIRO AK, FULOP GK et al. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1989 ; 46 : 722-30.
58. SHARMA R, TRAPPLER B, NG YK, LEEMAN CP. Risperidone-induced neuroleptic malignant syndrome. Ann Pharmacother 1996 ; 30 : 775-8.
59. SIMEON JG, CARREY NJ, WIGGINS DM et al. Risperidone effects in treatment-resistant adolescents : preliminary case reports. J Child Adolesc Psychopharmacol 1995 ; 5 : 69-79.
60. STAMENKOVIC M, ASCHAUER H, KASPER S. Risperidone for Tourette's syndrome. Lancet 1994 ; 344 : 1577-8.
61. STERNLICHT HC, WELLS SR. Risperidone in childhood schizophrenia [letter]. J Am Acad Child Adolesc Psychiatry 1995 ; 34 : 540.
62. TOWBIN KE, DYKENS EM, PUGLIESE RG. Clozapine for early developmental delays with childhood onset schizophrenia : protocol and 15-month outcome. J Am Acad Child Adolesc Psychiatry 1994 ; 33 : 651-7.
63. VAN DER LINDEN C, BRUGGEMAN R, VAN WOERKOM T. Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome : an open pilot dose-titration study with risperidone. Mov Disord 1994 : 687-8.
64. VANDEN BORRE, VERMOTE R, BUTTIENS M et al. Risperidone as add-on therapy in behavioural disturbances in mental retardation : a double-blind placebo-controlled cross-over study. Acta Psychiatr Scand 1993 ; 87 : 167-71.
65. VANELLE JM, OLIE JP, LEVY-SOUSSAN P. New antipsychotics in schizophrenia : the French experience. Acta Psychiatr Scand 1994 ; 89 (Suppl 380) : 59-63.
66. VYBOROVA L, NAHUNEK K, BALASTIKOVA B. Comparison of clozapine and chlorpromazine effects in children with the hyperactive syndrome. A controlled study. Ser Med Fac Med Brun 1979 ; 403 : 403-13.
67. WOERNER MG, SHEITMAN BB, LIEBERMAN JA et al. Tardive dyskinesia induced by risperidone ? [letter]. Am J Psychiatry 1996 ; 153 : 843.